We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume | Trades |
---|---|---|---|---|---|---|
AUNOC | Aurumin Limited | 0.005 | 0.003 | 150.00% | 8,369,788 | 6 |
MRD | Mount Ridley Mines Ltd | 0.002 | 0.001 | 100.00% | 598,894 | 3 |
UNTOA | Unith Ltd | 0.005 | 0.002 | 66.67% | 450,000 | 5 |
FRE | Firebrick Pharma Ltd | 0.081 | 0.03 | 58.82% | 9,073,276 | 459 |
NWMO | Norwest Minerals Limited | 0.015 | 0.005 | 50.00% | 625,000 | 6 |
MTMO | MTM Critical Metals Ltd | 0.003 | 0.001 | 50.00% | 531,250 | 3 |
TG1O | TechGen Metals Ltd | 0.003 | 0.001 | 50.00% | 120,458 | 1 |
BUR | Burley Minerals Ltd | 0.065 | 0.018 | 38.30% | 1,309,622 | 45 |
SFG | Seafarms Group Limited | 0.004 | 0.001 | 33.33% | 417,160 | 3 |
IEC | Intra Energy Corporation Ltd | 0.002 | 0.0005 | 33.33% | 675,000 | 4 |
MEG | Megado Minerals Ltd | 0.013 | 0.003 | 30.00% | 318,437 | 7 |
HONG KONG, April 17, 2024 /PRNewswire/ -- ICZOOM Group Inc. (Nasdaq: IZM) (the "Company" or "ICZOOM"), announced today that it voluntarily requested a withdrawal of a registration statement on Form F-1 filed with the U.S. Securities and Exchange Commission (File No.333-275708, the "Registration Statement") and accordingly cancelled the proposed public offering pursuant to the Registration Statement .
WASHINGTON, April 17, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. ("Vanda" or the "Company") (Nasdaq: VNDA) today announced that its Board of Directors (the "Board") has adopted a limited duration stockholder rights plan (the "Rights Plan") to protect stockholder interests and maximize value for all stockholders. The Rights Plan is effective immediately.
CHANGZHOU, China, April 17, 2024 /PRNewswire/ -- EZGO Technologies Ltd. (Nasdaq: EZGO) ("EZGO" or "we," "our," or the "Company"), a leading short-distance transportation solutions provider in China, today announced that it entered into a five-year strategic cooperation framework agreement (the "Agreement") with Woteam New Energy (Guangdong) Co., Ltd. ("Woteam"), a high-tech enterprise engaged in the research, development, production and sales of electric bicycle batteries, electric tool batteries, robot batteries, photovoltaic energy storage batteries and other products. EZGO and Woteam aim to jointly develop a series of automotives and electric products to meet local needs in the Southeast Asian market, and to enhance ...
Sage Therapeutics, Inc. (Nasdaq: SAGE) announced today topline results from PRECEDENT, a double-blind, placebo-controlled Phase 2 study of the investigational oral medicine dalzanemdor (SAGE-718) in people with mild cognitive impairment (MCI) in Parkinson’s Disease (PD). The PRECEDENT Study did not meet its primary endpoint of demonstrating statistically significant difference from baseline in participants treated with once-daily dalzanemdor versus placebo on the Wechsler Adult Intelligence Scale Fourth Edition-IV (WAIS-IV) Coding Test score at Day 42. Dalzanemdor (SAGE-718) was generally well-tolerated, and there were no new safety signals observed.
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 60,951.28 | -2,892.68 | -4.53% | 1.19T | 5,432,939,068 |
ETH | Ethereum | 2,973.15 | -111.67 | -3.62% | 354.88B | 2,350,726,982 |
USDT | Tether USD | 0.99999 | -0.00001 | 0.00% | 97.84B | 413,730,249 |
BNB | Binance Coin | 525.97 | -12.17 | -2.26% | 82.86B | 374,366,134 |
SOL | Solana | 130.47 | -5.90 | -4.33% | 57.09B | 2,047,685,035 |
STETH | stETH | 2,965.37 | -98.91 | -3.23% | 28.8B | 8,431,349 |
USDC | USD Coin | 0.9999 | -0.0001 | -0.01% | 28.07B | 939,724,896 |
XRP | Ripple | 0.4832 | -0.0135 | -2.72% | 26.2B | 379,444,668 |
TONCOIN | Wrapped TON Coin | 6.14 | -0.218977 | -3.45% | 21.15B | 218,332,272 |
DOGE | Dogecoin | 0.14808 | -0.00797 | -5.11% | 21.04B | 624,521,276 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions